Selexipag for Pulmonary Arterial Hypertension User Reviews (Page 2)
Brand names: Uptravi
Selexipag has an average rating of 5.2 out of 10 from a total of 23 reviews for the treatment of Pulmonary Arterial Hypertension. 22% of reviewers reported a positive experience, while 30% reported a negative experience.
Reviews for Selexipag
- Anonymous
- Taken for 1 to 6 months
- April 18, 2021
Uptravi (selexipag) "I cannot stand the pain of 400mcg twice a day, so I'm going to ask my pulminologist to put me back to 200mcg twice a day. I'm not willing to live with this pain if I don't have to"
- colleen
- Taken for 1 to 6 months
- December 5, 2023
Uptravi (selexipag) "I am now at 1000 a day and night, 800 was hard. I was having really bad back pain on my left side, once that subsided, I slowly went up. So far, I've noticed my breathing is better."
Frequently asked questions
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Pulmonary Arterial Hypertension
Care guides
Medicine.com guides (external)
More about selexipag
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: agents for pulmonary hypertension
- En español
Patient resources
- Selexipag oral/injection drug information
- Selexipag (Intravenous) (Advanced Reading)
- Selexipag (Oral) (Advanced Reading)
"Seriously had to call 911 cause I felt like I was dying - I had aches pains and throwing up! Never take this drug - I was taking only 200 micrograms . Which is the lowest !"